- Home
- GNLX vs ESSA Comparison
GNLX vs ESSA Comparison
Compare GNLX & ESSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- ESSA
- Stock Information
- Founded
- GNLX 2001
- ESSA 1916
- Country
- GNLX United States
- ESSA United States
- Employees
- GNLX N/A
- ESSA N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- ESSA Banks
- Sector
- GNLX Health Care
- ESSA Finance
- Exchange
- GNLX Nasdaq
- ESSA Nasdaq
- Market Cap
- GNLX 184.4M
- ESSA N/A
- IPO Year
- GNLX 2023
- ESSA N/A
- Fundamental
- Price
- GNLX $2.70
- ESSA $18.85
- Analyst Decision
- GNLX Strong Buy
- ESSA
- Analyst Count
- GNLX 4
- ESSA 0
- Target Price
- GNLX $18.25
- ESSA N/A
- AVG Volume (30 Days)
- GNLX 167.0K
- ESSA 15.6K
- Earning Date
- GNLX 03-28-2025
- ESSA 04-23-2025
- Dividend Yield
- GNLX N/A
- ESSA 3.20%
- EPS Growth
- GNLX N/A
- ESSA N/A
- EPS
- GNLX N/A
- ESSA 1.74
- Revenue
- GNLX $8,000.00
- ESSA $67,430,000.00
- Revenue This Year
- GNLX N/A
- ESSA $9.38
- Revenue Next Year
- GNLX N/A
- ESSA N/A
- P/E Ratio
- GNLX N/A
- ESSA $10.88
- Revenue Growth
- GNLX N/A
- ESSA N/A
- 52 Week Low
- GNLX $1.60
- ESSA $15.29
- 52 Week High
- GNLX $6.50
- ESSA $22.22
- Technical
- Relative Strength Index (RSI)
- GNLX 32.11
- ESSA 39.23
- Support Level
- GNLX $3.03
- ESSA $18.93
- Resistance Level
- GNLX $3.35
- ESSA $19.38
- Average True Range (ATR)
- GNLX 0.36
- ESSA 0.30
- MACD
- GNLX -0.11
- ESSA 0.02
- Stochastic Oscillator
- GNLX 0.00
- ESSA 16.36
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.